Genetic Insights: 25% of Patients May Need Medication Adjustments

Date:

Share post:

A significant factor that your physician might overlook when prescribing medication lies within your DNA.

A recent study released on Wednesday in Science Translational Medicine revealed that almost 25% of participants were given medications that might have required a different type or dosage based on their genetic information.

Conducted by researchers from the University of Pittsburgh, the study focused on 16 genes influencing how the body reacts to various medications.

The analysis involved DNA samples from 98,590 individuals enrolled in the National Institutes of Health’s All of Us Research Program, correlating them with available medical records.

Each individual had at least one pertinent genetic variation that could alter their response to specific medications, with the average participant showing nine variations. Among those with both genetic and clinical data, 24.4% had received at least one medication that, according to genetic guidelines, should have been substituted with another drug or adjusted in dosage.

However, the research did not ascertain whether patients experienced adverse effects or if their medications were less effective due to their genetic traits.

Dr. Philip Empey, the study’s senior author and an associate professor at the University of Pittsburgh School of Pharmacy, stated that understanding a patient’s genetic profile could alleviate the trial-and-error approach often associated with medication.

“Anything we can do to better predict upfront which medicines are optimal and what the best dosages should be can significantly minimize trial and error,” he remarked.

A woman in a medical mask sorts pills on a counter.

A pharmacist organizes medications at a pharmacy in Vancouver in October 2022. Genetic variations can influence how patients react to certain medications, which may necessitate dose adjustments or alternative prescriptions. (Darryl Dyck/The Canadian Press)

Identifying the Correct Medication

Among the most frequently prescribed medications for participants with genetic profiles suggesting potential treatment modifications were omeprazole and pantoprazole for acid reflux, as well as atorvastatin for cholesterol management.

Empey notes that certain genetic variations can heighten the risk of muscle-related issues in patients taking statins like atorvastatin, commonly prescribed to mitigate the risk of heart attacks or strokes.

This insight could guide healthcare providers in selecting an alternative medication or modifying treatment plans.

“It empowers clinicians to make more informed decisions, suggesting alternatives such as, ‘Perhaps we should not use that cholesterol medication. Maybe we start with a lower dose, consider maximum limits, or monitor for specific toxicities more closely,'” Empey explained.

In some instances, the implications of incorrect medication can be more severe.

Experts consulted by CBC News indicate that genetic testing can help pinpoint patients who may not respond effectively to clopidogrel (Plavix), a medication prescribed to prevent blood clots post-cardiac stenting, enabling physicians to opt for a different treatment option.

A man in a suit and tie sits in a laboratory.

Dr. James Kennedy leads the Tanenbaum Centre for Pharmacogenetics at Toronto’s Centre for Addiction and Mental Health. He emphasizes that while genetic testing can assist in medication selection, other factors such as diet, lifestyle, and existing medications must also be taken into account. (CBC)

A Framework, Not a Certainty

Dr. James Kennedy, head of the Tanenbaum Centre for Pharmacogenetics at Toronto’s Centre for Addiction and Mental Health (CAMH), remarked that the findings of the study were not unexpected, although he was particularly impressed by the genetic diversity and representation of individuals of African descent.

Kennedy’s team has conducted genetic testing for around 11,000 patients, many of whom have already tried multiple antidepressants without achieving desired results.

Approximately 8% to 10% of individuals metabolize certain commonly prescribed antidepressants at an unusually slow rate, potentially leading to harmful accumulation of the medication, he noted.

Kennedy highlighted that genetic testing is particularly beneficial for patients who have encountered difficulties with various medications.

However, he cautioned that DNA testing alone cannot predict a patient’s response to a medication. Other aspects, such as the patient’s current medications, smoking habits, and dietary choices, also play a crucial role.

“We provide a blueprint indicating your tendencies, but we also consider all other relevant factors before reaching a final conclusion,” he stated.

A 2023 European clinical trial referenced in the study found that conducting genetic testing prior to prescribing certain medications led to a decrease in adverse drug reactions. However, integrating such testing into routine practice in Canada poses challenges.

A person in purple gloves points to a small plastic test tube.

A researcher at the University of Calgary demonstrates a diagnostic kit used to identify genetic variations in February 2024. While such testing could assist doctors in customizing medications for individual patients, practical and financial hurdles have limited its widespread implementation in Canada. (Jeff McIntosh/The Canadian Press)

Barriers to Widespread Testing in Canada

Dr. Jacob Udell, a cardiologist in Toronto, found the study noteworthy, particularly for its genetic diversity among participants. However, he pointed out that few healthcare providers in Canada or the U.S. typically assess patients for genetic variations that could influence their medication metabolism.

“This is not typically on the radar of frontline healthcare providers,” he remarked.

Udell explained that for numerous conditions, physicians can prescribe a medication, observe the patient’s reaction, and make necessary adjustments without severe consequences. This method can often be more practical than routinely screening for genetic variations.

He also expressed skepticism about the priority of broad testing in light of Canada’s healthcare system challenges in delivering fundamental services.

“Currently, we are focused on ensuring everyone has a family doctor,” he noted.

In addition to the costs associated with testing, Udell mentioned that clinicians would require access to genetic test results and the expertise to interpret them.

Empey concurred that for genetic testing to become standard practice, substantial investment in training, infrastructure, and new systems for sharing results among healthcare providers would be necessary.

“The scientific foundation for many medications is robust. The challenge of implementation revolves more around economic factors, processes, and education,” he explained.

Currently, Empey advises that patients inquire with their doctors or pharmacists about the potential benefits of genetic testing and share any relevant results with them.

Udell cautioned that private genetic testing may become more prevalent among patients who can afford it, “but this won’t assist those who cannot pay for the testing.”

Related articles

Amnesty Report: Iran’s Crackdown on Protests Reflects Systematic Violence

Four years following the passing of a young woman whose name has become emblematic of the struggle for...

Military Time Edges Out Brachetto to Win Prince of Wales Stakes

Military Time edged past Brachetto just before crossing the finish line to win the $500,000 Prince of Wales...

Fresh Prep Foods Set to Acquire Troubled Rival Goodfood Market

Fresh Prep Foods Inc., a meal delivery service from Canada, has announced that it has obtained judicial approval...

Star Wars: A New Hope Returns to Theaters for 50th Anniversary!

Did you miss the original release of Star Wars back in 1977? Perhaps you found it unappealing, didn't...